Aberdeen Group Portfolio holdings
Aberdeen Group is a British wealth and investment company, created in 2017 when Standard Life merged with Aberdeen Asset Management. In 2018 it agreed to sell the Standard Life insurance business to Phoenix Group, shifting the company from insurance toward asset management. After selling the Standard Life name to Phoenix Group in 2021 it rebranded as abrdn, a vowel-free name that drew criticism, and in 2025 it went back to Aberdeen. Among its businesses is Interactive Investor, a British retail investing service that runs on subscriptions, which it bought in 2022.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$319M |
| 2 |
Amazon
AMZN
|
+$165M |
| 3 |
Microsoft
MSFT
|
+$110M |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$92.7M |
| 5 |
UnitedHealth
UNH
|
+$69.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$182M |
| 2 |
RTX Corp
RTX
|
+$97.9M |
| 3 |
Marvell Technology
MRVL
|
+$81.2M |
| 4 |
GE Vernova
GEV
|
+$80.7M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$73.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.75% |
| 2 | Healthcare | 12.68% |
| 3 | Consumer Discretionary | 10.96% |
| 4 | Communication Services | 10.76% |
| 5 | Financials | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
651
Travere Therapeutics
TVTX
$4.64B
| $7.09M | 0.01% |
124,855
-432,292
| -78% | -$19.2M |
2024 Q4
6 quarters
|
|
652
Relay Therapeutics
RLAY
$3.79B
| $6.96M | 0.01% |
+372,169
| New | +$5.4M |
2026 Q2
0 quarters
|
|
653
Coherent
COHR
$39.4B
| $6.95M | 0.01% |
17,625
+1,178
| +7% | +$417K |
2026 Q1
1 quarter
|
|
654
Petrobras
PBR
$136B
| $6.79M | 0.01% |
420,083
-166,252
| -28% | -$3.25M |
2022 Q1
17 quarters
|
|
655
News Corp Class A
NWSA
$16B
| $6.79M | 0.01% |
273,322
-7,696
| -3% | -$199K |
2017 Q3
35 quarters
|
|
656
Jack Henry & Associates
JKHY
$11.5B
| $6.76M | 0.01% |
49,073
+1,159
| +2% | +$164K |
2018 Q2
32 quarters
|
|
657
Seaport Therapeutics
SPTX
$1.07B
| $6.74M | 0.01% |
+310,355
| New | +$5.46M |
2026 Q2
0 quarters
|
|
658
Berkshire Hathaway Class A
BRK.A
$1.19T
| $6.74M | 0.01% |
9
-42
| -82% | -$30.3M |
2017 Q3
35 quarters
|
|
659
Patrick Industries
PATK
$2.63B
| $6.73M | 0.01% |
74,963
+18,111
| +32% | +$1.73M |
2026 Q1
1 quarter
|
|
660
Tyson Foods
TSN
$20.1B
| $6.71M | 0.01% |
117,155
-810
| -0.7% | -$50.7K |
2017 Q3
35 quarters
|
|
661
Tandem Diabetes Care
TNDM
$1.3B
| $6.67M | 0.01% |
441,738
+7,711
| +2% | +$135K |
2024 Q3
7 quarters
|
|
662
Immatics
IMTX
$1.07B
| $6.62M | 0.01% |
653,604
-167,113
| -20% | -$1.77M |
2024 Q3
7 quarters
|
|
663
Repligen
RGEN
$11B
| $6.6M | 0.01% |
48,404
-22,091
| -31% | -$2.71M |
2025 Q2
4 quarters
|
|
664
Tapestry
TPR
$24B
| $6.57M | 0.01% |
44,909
+4,467
| +11% | +$640K |
2017 Q3
35 quarters
|
|
665
Sagimet Biosciences
SGMT
$687M
| $6.55M | 0.01% |
+847,700
| New | +$5.76M |
2026 Q2
0 quarters
|
|
666
HubSpot
HUBS
$11.6B
| $6.53M | 0.01% |
35,765
-5,463
| -13% | -$1.14M |
2020 Q4
22 quarters
|
|
667
CareDx
CDNA
$4.51B
| $6.41M | 0.01% |
224,829
-192,915
| -46% | -$4.2M |
2025 Q4
2 quarters
|
|
668
MP Materials
MP
$6.83B
| $6.35M | 0.01% |
113,406
+12,268
| +12% | +$747K |
2024 Q2
8 quarters
|
|
669
Invesco QQQ Trust
QQQ
$460B
| $6.35M | 0.01% |
8,625
+1,691
| +24% | +$1.16M |
2025 Q2
4 quarters
|
|
|
PCSC
670
DELISTED
Perceptive Capital Solutions
PCSC
| $6.29M | 0.01% |
578,565
| – | – |
2025 Q4
2 quarters
|
|
671
UDR
UDR
$11.5B
| $6.29M | 0.01% |
157,458
+2,590
| +2% | +$95.8K |
2017 Q3
35 quarters
|
|
672
LTC Properties
LTC
$2.43B
| $6.12M | 0.01% |
159,038
-42,121
| -21% | -$1.6M |
2021 Q2
20 quarters
|
|
673
Northrop Grumman
NOC
$78.9B
| $5.99M | 0.01% |
11,770
-51
| -0.4% | -$29.4K |
2017 Q3
35 quarters
|
|
674
Emcor
EME
$29.9B
| $5.98M | 0.01% |
7,209
-995
| -12% | -$842K |
2024 Q2
8 quarters
|
|
675
Futu Holdings
FUTU
$14.5B
| $5.97M | 0.01% |
63,640
+11,125
| +21% | +$1.42M |
2021 Q3
19 quarters
|
|
Similar funds
Aberdeen Group's Q2 2026 Portfolio in Review
As of Q2 2026, Aberdeen Group held 978 positions worth $71.2B, up 15% from $61.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Aberdeen Group's Q2 2026 filing shows 47 new, 453 increased, 412 reduced and 44 closed positions. Its largest new stake was Honeywell Aerospace: 420,093 shares worth $92.9M. The largest sale was Honeywell, an estimated $182M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Aberdeen Group's largest Q2 2026 buy was Honeywell Aerospace: 420,093 shares worth $92.9M.
- Aberdeen Group added most to Tesla in Q2 2026, an estimated $319M increase.
- Aberdeen Group's biggest Q2 2026 reduction was RTX Corp, cutting an estimated $97.9M.
- Aberdeen Group fully exited Honeywell in Q2 2026, selling an estimated $182M.
- Aberdeen Group's ten largest holdings make up 37% of its $71.2B portfolio in Q2 2026.
- Aberdeen Group opened 47 new positions and closed 44 in Q2 2026.
- Aberdeen Group's portfolio value rose 15% quarter-over-quarter to $71.2B.
Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.